Jeanne Erdmann is an award-winning health and science writer based in Wentzville, Mo. A member of Association of
Health Care Journalists board of directors, she is the chair of the organization’s Freelance Committee. Her work has appeared in Discover, Women’s Health, Aeon, Slate, The Washington Post, Nature, Nature Medicine and other publications. You can follow her at @jeanne_erdmann.
Jeanne Erdmann
From this contributor
Analysis pins down prevalence of mental health conditions in autism
Eight mental health conditions occur unusually often in autistic people, a new analysis suggests.
Analysis pins down prevalence of mental health conditions in autism
By
Jeanne Erdmann
7 October 2019 | 2 min read
Drug screen reveals potential treatments for Rett syndrome
An experimental leukemia drug and a chemical in black pepper ease breathing and movement problems in a mouse model of Rett syndrome.
Drug screen reveals potential treatments for Rett syndrome
By
Jeanne Erdmann
11 September 2019 | 4 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read